Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 03-2017 | 03-2016 | 03-2015 | 03-2014 | |
| Sales | 7,459 | 9,638 | 12,498 | 5,015 | 4,601 |
| Cost of Goods | 3,511 | 5,898 | 4,484 | 3,014 | 3,236 |
| Gross Profit | 3,948 | 3,739 | 8,014 | 2,002 | 1,365 |
| Operating Expenses | 13,510 | 11,994 | 16,815 | 18,522 | 6,885 |
| Operating Income | -9,051 | -7,356 | -8,317 | -16,507 | -5,284 |
| Interest Expense | 336 | 238 | 281 | 287 | 900 |
| Other Income | 4,668 | 9,538 | 7,394 | 22,012 | -35,370 |
| Pre-tax Income | -4,719 | 1,944 | -1,204 | 5,217 | -41,554 |
| Income Tax | -1,046 | -1,868 | -521 | -3 | -293 |
| Net Income Continuous | -3,673 | 3,811 | -683 | 5,221 | -41,261 |
| Net Income | $-3,673 | $3,811 | $-683 | $5,221 | $-41,261 |
| EPS Basic Total Ops | 0.00 | 0.03 | -0.01 | 0.05 | -0.21 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | -0.09 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.21 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,055 | $-6,641 | $-7,650 | $-15,925 | $-4,830 |